• R A Yeager, G L Moneta, J M Edwards, L M Taylor, D B McConnell, and J M Porter.
• Department of Surgery, Oregon Health Sciences University, Portland, USA.
• Arch Surg Chicago. 1995 Aug 1;130(8):869-72; discussion 872-3.

ObjectiveTo determine which perioperative variables may influence the occurrence of perioperative myocardial infarction (PMI) following vascular surgery.DesignCase-control study.SettingCombined Veterans Affairs Medical Center-university hospital vascular service.PatientsDuring a 4-year period, all major vascular surgical operations (N = 2088) were evaluated with serial postoperative electrocardiography and cardiac enzyme measurements. Patients with PMI following nonemergent vascular surgery (N = 53) were matched with randomly selected control patients without PMI (N = 106) for age, gender, type of operation, hypertension, and symptoms of coronary artery disease.Main Outcome MeasuresThe two groups were compared for operative blood loss, blood pressure, and heart rate as well as length of operation, type of anesthetic, and use of perioperative beta-blockers, nitroglycerine, calcium channel blockers, vasopressors, and angiotensin-converting enzyme inhibitors.Resultsbeta-Blockers were used less frequently in patients with PMI than in control patients without PMI (30% vs 50%; P = .01). Overall beta-blockade was associated with a 50% reduction in PMI (P = .03). Perioperative myocardial infarction was not associated with length of operation, type of anesthetic, blood pressure, or use of other medications.Conclusionsbeta-Blockade is associated with a decreased incidence of PMI in patients undergoing vascular surgery. Prophylactic perioperative use of beta-blockers may decrease PMI in patients requiring major vascular surgery. A prospective randomized trial of beta-blockers in these patients appears to be warranted.

22 keywords...

hide…